Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See details about our updated masking policy »

Autologous Blood and Marrow Transplantation
About this Treatment
Overview Techniques Risks
Patient Care Resources
Autologous Blood and Marrow Transplantation
About this Treatment
Overview Techniques Risks
Patient Care Resources

About this Treatment: Autologous Blood and Marrow Transplantation

About Autologous Blood and Marrow Transplantation

The principle behind an autologous  blood and marrow transplant (BMT) is to begin with high doses of chemotherapy to more aggressively treat cancer.  After the high dose chemotherapy, you are infused with your previously collected and stored stem cells to help your blood counts recover from the high dose chemotherapy.

An autologous BMT is done for patients diagnosed with lymphoma, multiple myeloma, and germ cell tumors such as testicular cancer. Autologous BMT may be recommended, if the disease:

  • Didn’t improve or respond to the drug therapy
  • Returned after completing drug therapy (this is called recurrence)
Make An Appointment

To schedule an appointment, please call: 888-888-8888

Learn More About Autologous Blood and Marrow Transplant

About this Treatment

Learn about the conditions treated, techniques, and risks of autologous blood and marrow transplant.

Patient Care Resources

Learn what to expect as you go through the early steps of your care.